Treatment of Dyslipidmia.
10.5124/jkma.2010.53.3.204
- Author:
Ji Dong SUNG
1
Author Information
1. Division of Cardiology, Department of Internal Medicine, Sungkyunkwan University School of Medicine, Korea. jidong.sung@samsung.com
- Publication Type:Original Article
- Keywords:
Dyslipidemia;
Coronary artery disease;
Prevention
- MeSH:
Cardiovascular Diseases;
Coronary Artery Disease;
Dyslipidemias;
Hand;
Humans;
Life Style;
Primary Prevention;
Public Health;
Publications
- From:Journal of the Korean Medical Association
2010;53(3):204-207
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Treatment of dyslipidemia is apparently one of the most important measures for prevention of atherosclerotic cardiovascular diseases. Recent trend reflecting several study results after publication of the ATP-III guideline in 2001 recommends more aggressive target LDL goals in very high risk patients. On the other hand, public health approaches, such as life style modification, to low risk group should not be neglected for primary prevention to avoid life-long medication in undesirably large number of people. Intensity of the treatment must be adjusted after a careful consideration of each patient's global risk, not just by lipid level alone. More attention to dyslipidemia management is needed for both clinical and public health perspectives.
